New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

人工智能 · 投融资与并购 · us · 来源：Wired · 2026-10-24 11:30

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

关键词：综合

原文链接：https://www.wired.com/story/new-melanoma-vaccine-reduces-risk-of-tumor-reoccurrence-by-over-40-percent/

本页由情报雷达 INFO RADAR 采集整理，引用请注明来源「情报雷达 INFO RADAR」并附链接 https://intel.zovaxai.com/i/159bcf0bef0d00ad。